Progression of Gastrointestinal Injury During Antiplatelet Therapy After Percutaneous Coronary Intervention: A Secondary Analysis of the OPT-PEACE Randomized …
C He, Y Li, X Jiang, MN Jiang, XX Zhao… - JAMA Network …, 2023 - jamanetwork.com
Importance Gastrointestinal injury progression induced by antiplatelet therapy in patients
after percutaneous coronary intervention (PCI) has not been well studied. Objective To …
after percutaneous coronary intervention (PCI) has not been well studied. Objective To …
Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: rationale and design of the OPT …
Y Li, X Wang, D Bao, Z Liao, J Li, X Han, H Wang… - American Heart …, 2020 - Elsevier
Background Gastrointestinal injury is a common complication in patients treated with
antiplatelet agents after percutaneous coronary intervention (PCI). However, the effects of …
antiplatelet agents after percutaneous coronary intervention (PCI). However, the effects of …
Magnetically controlled capsule endoscopy for assessment of antiplatelet therapy–induced gastrointestinal injury
Y Han, Z Liao, Y Li, X Zhao, S Ma, D Bao, M Qiu… - Journal of the American …, 2022 - jacc.org
Background Gastrointestinal bleeding is the most frequent major complication of antiplatelet
therapy. In patients at low bleeding risk, however, clinically overt gastrointestinal bleeding is …
therapy. In patients at low bleeding risk, however, clinically overt gastrointestinal bleeding is …
Inflammation in plaque erosion and rupture
K Huynh - Nature Reviews Cardiology, 2022 - nature.com
In the randomized OPT-PEACE trial, almost all patients receiving dual antiplatelet therapy
(DAPT) after percutaneous coronary intervention (PCI), including those at low risk of …
(DAPT) after percutaneous coronary intervention (PCI), including those at low risk of …
Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention …
A Hara, K Ota, T Takeuchi, Y Kojima… - Journal of Clinical …, 2018 - jstage.jst.go.jp
抄録 Although low-dose aspirin (LDA) is known to induce small intestinal mucosal injury, the
effect of dual antiplatelet therapy (DAPT; LDA+ clopidogrel) on small intestinal mucosa in …
effect of dual antiplatelet therapy (DAPT; LDA+ clopidogrel) on small intestinal mucosa in …
[HTML][HTML] Gastrointestinal injury caused by aspirin or clopidogrel monotherapy versus dual antiplatelet therapy
JA Bittl, L Laine - Journal of the American College of Cardiology, 2022 - jacc.org
Patients who undergo percutaneous coronary intervention (PCI) with drug-eluting stents
require dual antiplatelet therapy (DAPT) for at least 6 months for stable ischemic heart …
require dual antiplatelet therapy (DAPT) for at least 6 months for stable ischemic heart …
[HTML][HTML] Comparison of the degree of gastric mucosal injury between patients who are receiving dual antiplatelet therapy or single antiplatelet therapy
Y Shimada, M Hojo, Y Kita, Y Ikeda, S Sato, A Murata… - Diagnostics, 2022 - mdpi.com
Background: Patients taking low-dose aspirin have a higher incidence of gastroduodenal
ulcers and higher risk of upper gastrointestinal bleeding than patients who do not …
ulcers and higher risk of upper gastrointestinal bleeding than patients who do not …
Trials of dual antiplatelet therapy after percutaneous coronary intervention lack strategies to ensure appropriate gastroprotection
METHODS: A methodological review of randomized trials comparing varying durations of
DAPT after percutaneous coronary intervention. RESULTS: Among 21 trials, none …
DAPT after percutaneous coronary intervention. RESULTS: Among 21 trials, none …
Gastrointestinal bleeding after percutaneous coronary intervention
T Tanigawa, T Watanabe, Y Nadatani, K Otani… - Digestion, 2011 - karger.com
Percutaneous coronary intervention (PCI) is now performed in a wide range of patients with
coronary artery disease. Complications of PCI include in-stent re-stenosis and in-stent …
coronary artery disease. Complications of PCI include in-stent re-stenosis and in-stent …
Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary …
NS Abraham, EH Yang, PA Noseworthy… - Alimentary …, 2020 - Wiley Online Library
Background Gastrointestinal bleeding (GIB) frequently occurs following percutaneous
coronary intervention (PCI) for acute coronary syndrome (ACS) with the prescription of …
coronary intervention (PCI) for acute coronary syndrome (ACS) with the prescription of …